END-STAGE LIVER DISEASE (ESLD)
Clinical trials for END-STAGE LIVER DISEASE (ESLD) explained in plain language.
Never miss a new study
Get alerted when new END-STAGE LIVER DISEASE (ESLD) trials appear
Sign up with your email to follow new studies for END-STAGE LIVER DISEASE (ESLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug make liver transplants safer?
Disease control Recruiting nowThis study tests whether a medicine called tranexamic acid can reduce blood loss during adult liver transplant surgery. About 1,546 people will be randomly assigned to receive either the drug or a placebo. The main goal is to see if the drug works better than placebo at controlli…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the thera…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC
-
Massive european study aims to redefine success in liver transplants
Knowledge-focused Recruiting nowThis study is collecting information from 10,000 liver transplant patients across Europe to create a new, up-to-date reference for what good outcomes look like when using machine perfusion (a technique that keeps donated livers healthier before transplant). The goal is to help do…
Matched conditions: END-STAGE LIVER DISEASE (ESLD)
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:09 UTC